
Sign up to save your podcasts
Or
Nandan Padukone, CEO of IM Therapeutics, headquartered in Woburn, Massachusetts, shares his thoughts with BioBoss host John Simboli about leadership and how IM Therapeutics is targeting the root cause of autoimmunity with therapeutic design directed at human leukocyte antigens.
5
77 ratings
Nandan Padukone, CEO of IM Therapeutics, headquartered in Woburn, Massachusetts, shares his thoughts with BioBoss host John Simboli about leadership and how IM Therapeutics is targeting the root cause of autoimmunity with therapeutic design directed at human leukocyte antigens.
1,040 Listeners
31 Listeners
274 Listeners
309 Listeners
331 Listeners
394 Listeners
122 Listeners
318 Listeners
198 Listeners
84 Listeners
88 Listeners
428 Listeners
147 Listeners
18 Listeners
84 Listeners